Add Yahoo as a preferred source to see more of our stories on Google. A professional in the event planning division of an international biotechnology trade group is running as a Democrat for the ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

GLP-1 drugs are taking much oxygen out of the biotechnology trade. However, many investors have been eyeing other areas in the sector, particularly cancer research. Novartis AG (NYSE: NVS) is up over ...

John Flavin , Portal Innovations CEO, joins 'Fast Money' to discuss if there is still room to run in the biotech space. Got a confidential news tip? We want to hear from you. Sign up for free ...

Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...

Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as a global biotech hub Legend Biotech received ...

Agricultural biotechnology, or “agri-biotech,” uses science to make plants better. Think of it like giving crops special ...

A professional in the event planning division of an international biotechnology trade group is running as a Democrat for the District 1 Frederick County Council seat, with a focus on data center ...